Cara Therapeutics's total assets for Q4 2023 were $27.00M, a decrease of -76.59% from the previous quarter. CARA total liabilities were $89.06M for the fiscal quarter, a 199.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.